A Randomized, Placebo-Controlled Trial of HPV Vaccination to Reduce Cervical High-Grade Squamous Intraepithelial Lesions Among HIV-Infected Women Participating in an HPV Test-and-Treat Program (COVENANT)

Status: Active, no longer recruiting

Phase of Trial: Phase III

Latest Information Update: 23 Jul 2024

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs V 503 (Primary)
Indications Cervical intraepithelial neoplasia; Squamous cell cancer
Focus Therapeutic Use
Acronyms COVENANT

Most Recent Events

17 Jul 2024 Planned primary completion date changed from 2 Dec 2024 to 16 Nov 2024.
22 Jan 2024 Planned primary completion date changed from 2 Dec 2025 to 2 Dec 2024.
20 Dec 2023 Planned primary completion date changed from 15 Mar 2025 to 2 Dec 2025.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com

Welcome to AdisInsight